Home / Core Business / Pharmaceutical & Biotechnology

Tianda Group, through Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”) (stock code: 00455), its Hong Kong main board listed subsidiary, is committed to research and development, manufacture and sales of pharmaceutical, biotechnology and healthcare products.

Headquartered in Hong Kong, Tianda Pharmaceuticals has set up its sales and distribution centres in Shenzhen and Sydney, and established two pharmaceutical R&D and production bases in Zhuhai and Kunming. Both production bases have acquired Good Manufacturing Practice (“GMP”) certifications issued by China Food and Drug Administration (“CFDA”). The production base in Zhuhai has even been awarded GMP certification by Therapeutic Goods Administration (“TGA”) of Australia. Tianda Pharmaceuticals’ product range covers Chinese and western medicines and biochemical drugs, etc., which include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, detoxification agents and other pharmaceutical products, as well as healthcare products under the self-owned brand of Herb Valley and others. Most of these products have been listed in China’s “National Basic Medical Insurance Drugs Catalogue” and “National Essential Drugs Catalogue”.

China is undergoing medical reform and Tianda Group is capitalising on this unique opportunity to actively expand its foothold in the medical industry, promoting advanced standards in the industry and upgrading the quality of the medical services in China.

“Tianda for Health!” is the corporate slogan of Tianda Pharmaceuticals, inspiring the continuous commitment to the passion and pursuit of health and care. Tianda Pharmaceuticals continues its endogenous development, and at the same time accelerates its external expansion through all forms of collaborations and capital market transactions. It is committed to developing into a leading pharmaceutical enterprise based in China with global presence.